Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: NZ$0.3 M
• Last 3 months FTD volume: NZ$3.02 M
• Last year FTD volume: NZ$3.02 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx RARE	NZ$0.76 M	NZ$6.92 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$4.17 M	NZ$17.05 M	🇺🇸 USA
Pfizer PFE	NZ$50.21 M	NZ$0.38 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	NZ$14.63 M	NZ$0.10 B	🇺🇸 USA
Amicus Therapeutics FOLD	NZ$0.11 M	NZ$6.18 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	NZ$2.68 M	NZ$21.62 M	🇺🇸 USA